Related Experiment Videos
Histidine-rich glycoprotein as a negative acute phase reactant.
American Journal of Hematology
|June 1, 1990
Summary
Serum histidine-rich glycoprotein, a key protein, was found to decrease during acute inflammation. This study confirms its role as a negative acute phase reactant, contrasting with C-reactive protein levels.
Area of Science:
- Biochemistry
- Immunology
- Clinical Chemistry
Background:
- Acute inflammation involves complex systemic responses.
- Acute phase reactants are proteins whose plasma concentrations change significantly during inflammation.
Purpose of the Study:
- To investigate the behavior of histidine-rich glycoprotein (HRG) during acute inflammation.
- To determine if HRG functions as an acute phase reactant.
Main Methods:
- Serum HRG levels were measured using the Laurell method.
- Measurements were taken in patients experiencing acute inflammation.
- Correlations with C-reactive protein (CRP) levels were analyzed.
Main Results:
- Serum HRG levels showed a significant negative correlation with CRP levels (P < 0.005).
- This inverse relationship was consistently observed in sequential patient monitoring.
- HRG levels decreased as inflammation markers, like CRP, increased.
Conclusions:
- Histidine-rich glycoprotein (HRG) is identified as a negative acute phase reactant.
- HRG levels decrease in response to acute inflammatory stimuli.
- This finding contributes to understanding the dynamic changes in serum proteins during inflammation.